Concomitant interleukin-2-doxorubicin (ADR) schedule in patients (PTS) with advanced soft tissue sarcomas (ASTS): A pharmacokinetic study

被引：0
|
作者：
LeCesne, A [1 ]
Vassal, G [1 ]
Farace, F [1 ]
Spielmann, M [1 ]
LeChevalier, T [1 ]
Tursz, T [1 ]
Escudier, B [1 ]
机构：
[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：586 / 586
页数：1
相关论文
共 50 条
  • [1] A phase lb study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).
    Davis, Lara E.
    Latour, Emile
    Burch, Reid
    Park, Byung
    Davis, Jessica L.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] A phase II study of raltitrexed ('Tomudex') as second or third line treatment for patients (pts) with advanced soft tissue sarcomas (ASTS) refractory to doxorubicin containing regimens
    Blay, JY
    Judson, I
    Rodenhuis, S
    Hermans, C
    Smith, M
    van Glabbeke, M
    Verweij, J
    ANNALS OF ONCOLOGY, 1998, 9 : 118 - 118
  • [3] CONCOMITANT LIPOSOMAL DOXORUBICIN AND DAILY PALLIATIVE RADIOTHERAPY IN ADVANCED FELINE SOFT TISSUE SARCOMAS
    Kleiter, Miriam
    Tichy, Alexander
    Willmann, Michael
    Pagitz, Maximillan
    Wolfesberger, Birgitt
    VETERINARY RADIOLOGY & ULTRASOUND, 2010, 51 (03) : 349 - 355
  • [4] Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).
    Chawla, Sant P.
    Blay, Jean-Yves
    Italiano, Antoine
    Gutierrez, Martin
    Le Cesne, Axel
    Gomez-Roca, Carlos Alberto
    Gouw, Launce G.
    von Mehren, Margaret
    Wagner, Andrew
    Maki, Robert G.
    Higgins, Brian
    Middleton, Steven
    Nichols, Gwen L.
    Geho, David
    Blotner, Steven
    Zhi, Jianguo
    Chen, Lin Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] CONCOMITANT RADIATION - DOXORUBICIN ADMINISTRATION IN LOCALLY ADVANCED AND OR METASTATIC SOFT-TISSUE SARCOMAS - PRELIMINARY-RESULTS
    TOMA, S
    PALUMBO, R
    SOGNO, G
    CANAVESE, G
    BARRA, S
    MARZIANO, C
    SERRANO, J
    ALBANESE, E
    ROSSO, R
    ANTICANCER RESEARCH, 1991, 11 (06) : 2085 - 2089
  • [6] Effect of metastasis surgery on overall survival in patients (pts) with advanced soft tissue sarcoma (ASTS): A subanalysis of the PALSAR trials
    Kotecki, Nuria
    Binh Bui Nguyen
    Blay, Jean-Yves
    Mathoulin-Pelissier, Simone
    Chevreau, Christine
    Thariat, Juliette
    Cupissol, Didier
    Bay, Jacques-Olivier
    Coindre, Jean-Michel
    Lotz, Jean-Pierre
    Jimenez, Marta
    Brouste, Veronique
    Guillemet, Cecile
    Italiano, Antoine
    Penel, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Standard-dose doxorubicin versus sequential dose-dense doxorubicin and ifosfamide in patients with untreated advanced soft tissue sarcoma (ASTS): A GEIS Study
    Maurel, J.
    Lopez-Pousa, A.
    de las Penas, R.
    Fra, J.
    Cruz, J.
    Martin, J.
    Casado, A.
    Martinez-Trufero, J.
    Poveda, A.
    Garcia del Muro, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Cardiac toxicity in a phase III study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas
    D'Adamo, DR
    Anderson, S
    Albritton, K
    Yamada, J
    Riedel, E
    Scheu, K
    Schwartz, GK
    Chen, H
    Maki, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 821S - 821S
  • [9] Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens
    Blay, JY
    Judson, I
    Rodenhuis, S
    Hermans, C
    Smith, M
    van Glabbeke, M
    Verweij, J
    ANTI-CANCER DRUGS, 1999, 10 (10) : 873 - 877
  • [10] Phase II trial of cetuximab in patients (pts) with metastatic and/or locally advanced soft tissue and bone sarcomas
    Ha, H. T.
    Chugh, R.
    Griffith, K. A.
    Thomas, D. G.
    Schuetze, S. M.
    Lucas, D. R.
    Biermann, J. S.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345